Power of big data to improve patient care in gastroenterology.

clinical trials health service research statistics

Journal

Frontline gastroenterology
ISSN: 2041-4137
Titre abrégé: Frontline Gastroenterol
Pays: England
ID NLM: 101528589

Informations de publication

Date de publication:
2022
Historique:
received: 08 02 2021
accepted: 23 05 2021
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 3 5 2022
Statut: epublish

Résumé

Big data is defined as being large, varied or frequently updated, and usually generated from real-world interaction. With the unprecedented availability of big data, comes an obligation to maximise its potential for healthcare improvements in treatment effectiveness, disease prevention and healthcare delivery. We review the opportunities and challenges that big data brings to gastroenterology. We review its sources for healthcare improvement in gastroenterology, including electronic medical records, patient registries and patient-generated data. Big data can complement traditional research methods in hypothesis generation, supporting studies and disseminating findings; and in some cases holds distinct advantages where traditional trials are unfeasible. There is great potential power in patient-level linkage of datasets to help quantify inequalities, identify best practice and improve patient outcomes. We exemplify this with the UK colorectal cancer repository and the potential of linkage using the National Endoscopy Database, the inflammatory bowel disease registry and the National Health Service bowel cancer screening programme. Artificial intelligence and machine learning are increasingly being used to improve diagnostics in gastroenterology, with image analysis entering clinical practice, and the potential of machine learning to improve outcome prediction and diagnostics in other clinical areas. Big data brings issues with large sample sizes, real-world biases, data curation, keeping clinical context at analysis and General Data Protection Regulation compliance. There is a tension between our obligation to use data for the common good and protecting individual patient's data. We emphasise the importance of engaging with our patients to enable them to understand their data usage as fully as they wish.

Identifiants

pubmed: 35493622
doi: 10.1136/flgastro-2019-101239
pii: flgastro-2019-101239
pmc: PMC8996101
doi:

Types de publication

Journal Article

Langues

eng

Pagination

237-244

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Colorectal Dis. 2017 Oct;32(10):1399-1406
pubmed: 28779355
Gut. 2021 Mar;70(3):537-543
pubmed: 32690602
BMC Med Res Methodol. 2019 Mar 19;19(1):64
pubmed: 30890124
Sci Rep. 2019 Dec 11;9(1):18892
pubmed: 31827222
Contemp Clin Trials. 2020 Jul;94:105856
pubmed: 31669449
Gastrointest Endosc. 2021 Mar;93(3):750-757
pubmed: 32891620
Perspect Biol Med. 2019;62(2):237-256
pubmed: 31281120
Gastrointest Endosc. 2012 Jun;75(6):1233-9.e14
pubmed: 22482913
Front Med (Lausanne). 2019 Mar 01;6:34
pubmed: 30881956
N Engl J Med. 2016 Aug 18;375(7):655-65
pubmed: 27532831
J Innov Health Inform. 2016 Dec 20;23(3):627-632
pubmed: 28059698
J Hepatol. 2012 Apr;56(4):848-54
pubmed: 22173164
BMJ. 2019 Jan 24;364:k5267
pubmed: 30679170
Endosc Int Open. 2020 Nov;8(11):E1545-E1552
pubmed: 33140009
BMC Cancer. 2017 Aug 14;17(1):543
pubmed: 28806955
Sci Rep. 2016 Nov 07;6:36493
pubmed: 27819294
BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000191
pubmed: 29607052
J Biomed Inform. 2017 Feb;66:82-94
pubmed: 28034788
Int J Epidemiol. 2020 Feb 1;49(1):16-16h
pubmed: 31120104
Gut. 2020 May;69(5):799-800
pubmed: 31615835
Endoscopy. 2014 Feb;46(2):90-7
pubmed: 24477363
Am J Epidemiol. 2016 Apr 15;183(8):758-64
pubmed: 26994063
J Epidemiol Community Health. 2019 Aug;73(8):778-785
pubmed: 31129565
United European Gastroenterol J. 2019 Jul;7(6):798-806
pubmed: 31316784
J Am Med Inform Assoc. 2016 Sep;23(5):879-90
pubmed: 26911814
BMJ Open. 2015 Aug 21;5(8):e008118
pubmed: 26297363
Lancet. 2019 Apr 27;393(10182):1708-1720
pubmed: 30935734
Int J Med Inform. 2018 Jun;114:57-65
pubmed: 29673604

Auteurs

Jamie Catlow (J)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK.

Benjamin Bray (B)

Medical Director & Head of Epidemiology, EMEA Data Science, IQVIA Europe, Reading, UK.
Medicine Clinical Academic Group, King's College London, London, UK.

Eva Morris (E)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK.

Matt Rutter (M)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK.

Classifications MeSH